This trial will test whether using a temporary circulatory assist device for 30 minutes prior to a catheterization procedure can reduce heart damage from a heart attack.
- ST Elevation Myocardial Infarction (STEMI)
1 Primary · 3 Secondary · Reporting Duration: 12 Months
Awards & Highlights
2 Treatment Groups
1 of 2
1 of 2
668 Total Participants · 2 Treatment Groups
Primary Treatment: Impella CP® placement prior to reperfusion with Primary PCI · No Placebo Group · N/A
Who is running the clinical trial?
Age 18 - 85 · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are patients of all ages eligible for this research?
"The age range for this study is 18 to 80 years old." - Anonymous Online Contributor
At how many institutions is this research being conducted?
"Enrollment for this clinical trial is currently taking place at University of Buffalo Hospital, The University of Texas Health Science Center at Houston, Sentara Norfolk General Hospital and an additional 46 medical facilities." - Anonymous Online Contributor
How many guinea pigs are a part of this experiment?
"That is correct. The study, which began recruiting on December 12th 2019, is still looking for 668 participants at 46 sites around the world according to the latest update from July 14th 2022." - Anonymous Online Contributor
Which patients would be a good match for this clinical trial?
"668 individuals aged 18-80 who have had an infarction are being recruited for this study. In order to participate, patients must meet the following age and presentation criteria: 18-80 years old and hospital arrival 1-5 hours after onset of ischemic pain." - Anonymous Online Contributor
Are people with the necessary qualifications currently being sought for this research project?
"That is correct. The clinical trial, which began recruitment on December 12th 2019, is still ongoing according to the information available on clinicaltrials.gov. There are currently 668 participants enrolled at 46 sites around the world." - Anonymous Online Contributor